Response to: Correspondence on 'Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients' by Trahtemberg et al.
Marvin J FritzlerUriel Trahtembergnull nullPublished in: Annals of the rheumatic diseases (2021)